4.3 Article

Value of the risk of ovarian malignancy algorithm index in predicting the recurrence of epithelial ovarian cancer

期刊

BIOMARKERS IN MEDICINE
卷 16, 期 14, 页码 1055-1066

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/bmm-2022-0287

关键词

CA125; epithelial ovarian cancer; FIGO; HE4; recurrence; ROMA index

资金

  1. Ningxia Key Research and Development Program [2019BFG02002]

向作者/读者索取更多资源

This study assessed the predictive and diagnostic value of the ROMA index for EOC recurrence. The results showed that the ROMA index was strongly associated with clinical characteristics and had a significant association with recurrence-free survival above the cutoff value. The ROMA index had a higher sensitivity than CA125 and HE4 for recurrence diagnosis.
Aim: This study aimed to assess the predictive and diagnostic value of the risk of ovarian malignancy algorithm (ROMA) index for epithelial ovarian cancer (EOC) recurrence. Materials & methods: The clinical features and follow-up data of 159 EOC cases were studied. The ROMA index was calculated by serum CA125 and HE4 levels with menopausal status. Recurrence-free survival was evaluated for an end point. Results: The ROMA was strongly associated with clinical characteristics. The ROMA index above the cutoff value (34.71%) was significantly associated with recurrence-free survival. The ROMA index had a significantly higher sensitivity (90.59%) than CA125 (84.71%) and HE4 (80.80%) for recurrence diagnosis, and its optimal cutoff value was 17.07%. Conclusion: The primary ROMA index is a predictive factor in EOC recurrence and has better performance in the diagnosis of EOC recurrence.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据